LA HB421 | 2024 | Regular Session
Status
Completed Legislative Action
Spectrum: Strong Partisan Bill (Democrat 17-1)
Status: Passed on June 11 2024 - 100% progression
Action: 2024-06-11 - Effective date: 08/01/2024.
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Strong Partisan Bill (Democrat 17-1)
Status: Passed on June 11 2024 - 100% progression
Action: 2024-06-11 - Effective date: 08/01/2024.
Text: Latest bill text (Chaptered) [PDF]
Summary
Provides relative to sickle cell disease management and treatment plan for students diagnosed with sickle cell disease (EN NO IMPACT See Note)
Title
Provides relative to sickle cell disease management and treatment plan for students diagnosed with sickle cell disease (EN NO IMPACT See Note)
Sponsors
Roll Calls
2024-05-29 - House - House Vote on HB 421 CONCUR IN SENATE AMENDMENTS (#1525) (Y: 87 N: 0 NV: 0 Abs: 18) [PASS]
2024-05-20 - Senate - Senate Vote on HB 421 FINAL PASSAGE (#987) (Y: 36 N: 0 NV: 0 Abs: 3) [PASS]
2024-04-04 - House - House Vote on HB 421 FINAL PASSAGE (#246) (Y: 104 N: 0 NV: 0 Abs: 1) [PASS]
2024-05-20 - Senate - Senate Vote on HB 421 FINAL PASSAGE (#987) (Y: 36 N: 0 NV: 0 Abs: 3) [PASS]
2024-04-04 - House - House Vote on HB 421 FINAL PASSAGE (#246) (Y: 104 N: 0 NV: 0 Abs: 1) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-06-11 | House | Effective date: 08/01/2024. |
2024-06-11 | House | Signed by the Governor. Becomes Act No. 616. |
2024-06-03 | House | Sent to the Governor for executive approval. |
2024-05-31 | Senate | Signed by the President of the Senate. |
2024-05-30 | House | Enrolled and signed by the Speaker of the House. |
2024-05-29 | House | Read by title, roll called, yeas 87, nays 0, Senate amendments concurred in. |
2024-05-29 | House | Called from the calendar. |
2024-05-29 | House | Read by title, returned to the calendar. |
2024-05-22 | House | Scheduled for concurrence on 05/29/2024. |
2024-05-20 | House | Received from the Senate with amendments. |
2024-05-20 | Senate | Rules suspended. The amended bill was read by title, passed by a vote of 36 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. |
2024-05-15 | Senate | Reported with Legislative Bureau amendments which were read and adopted. Read by title and passed to third reading and final passage. |
2024-05-14 | Senate | Read by title and referred to the Legislative Bureau. |
2024-05-14 | Senate | Rules suspended. Recalled from Committee. |
2024-05-13 | Senate | Read by title. Recommitted to the Committee on Finance. |
2024-05-13 | Senate | Senate Committee amendments read and adopted. |
2024-05-08 | Senate | Reported with amendments. |
2024-04-09 | Senate | Read second time by title and referred to the Committee on Health and Welfare. |
2024-04-08 | Senate | Received in the Senate. Read first time by title and placed on the Calendar for a second reading. |
2024-04-04 | House | Read third time by title, roll called on final passage, yeas 104, nays 0. Finally passed, title adopted, ordered to the Senate. |
2024-04-03 | House | Scheduled for floor debate on 04/04/2024. |
2024-04-02 | House | Read by title, ordered engrossed, passed to 3rd reading. |
2024-03-27 | House | Reported favorably (15-0). |
2024-03-11 | House | Read by title, under the rules, referred to the Committee on Health and Welfare. |
2024-02-29 | House | Under the rules, provisionally referred to the Committee on Health and Welfare. |
2024-02-29 | House | Prefiled. |